Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Yi H et al. | Direct evidence for the function of FUM13 in 3-ketoreduction of mycotoxin fumonisins in Fusarium verticillioides. | 2005 | J. Agric. Food Chem. | pmid:15969533 |
Grimm MO et al. | Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease. | 2011 | Int J Alzheimers Dis | pmid:21660213 |
Loewith R and Hall MN | Target of rapamycin (TOR) in nutrient signaling and growth control. | 2011 | Genetics | pmid:22174183 |
Nimrichter L and Rodrigues ML | Fungal glucosylceramides: from structural components to biologically active targets of new antimicrobials. | 2011 | Front Microbiol | pmid:22025918 |
Hanada K et al. | D-Serine inhibits serine palmitoyltransferase, the enzyme catalyzing the initial step of sphingolipid biosynthesis. | 2000 | FEBS Lett. | pmid:10828452 |
Ardail D et al. | Occurrence of ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria. | 2001 | FEBS Lett. | pmid:11163764 |
Koeller CM and Heise N | The Sphingolipid Biosynthetic Pathway Is a Potential Target for Chemotherapy against Chagas Disease. | 2011 | Enzyme Res | pmid:21603271 |
Schmitz-Peiffer C | Targeting ceramide synthesis to reverse insulin resistance. | 2010 | Diabetes | pmid:20876726 |
Uchida Y | The role of fatty acid elongation in epidermal structure and function. | 2011 | Dermatoendocrinol | pmid:21695014 |
Merrill AH | Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. | 2011 | Chem. Rev. | pmid:21942574 |